Lamotrigine Tablet, Orally Disintegrating
Product Images NDC 46708-770

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 46708-770). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 Tablets (Lamotrigine 100mg)

30 Tablets (Lamotrigine 100mg)
This text appears to be information about Lamotrigine Orally Disintegrating Tablets, USP in 100 mg strength. Please refer to the manufacturer's instructions or consult a healthcare professional for detailed usage guidelines and instructions.*
FDA Label Image

30 Tablets (Lamotrigine 200mg)

FDA Label Image

30 Tablets (Lamotrigine 25mg)

FDA Label Image

30 Tablets (Lamotrigine 50mg)

FDA Label Image

Lamotrigine-all-strength.jpg (Lamotrigine All Strength)

Lamotrigine-all-strength.jpg (Lamotrigine All Strength)
These are various doses of tablets available in 25mg, 50mg, 100 mg, and 200 mg strengths. The tablets are white to off-white in color and have different markings such as "10", "70", "*110", and "*770" for identification purposes.*
FDA Label Image

Lamotrigine-fig-1.jpg (Lamotrigine Fig 1)

Lamotrigine-fig-1.jpg (Lamotrigine Fig 1)
This text provides the failure probability percentage for Lamotrigine, which is indicated as 100%. Lamotrigine is likely to have a high failure rate based on this information.*
FDA Label Image

Lamotrigine-fig-2.jpg (Lamotrigine Fig 2)

FDA Label Image

Lamotrigine-structure.jpg (Lamotrigine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.